Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vascular pathobiology of pulmonary hypertension
Eunate Gallardo‐Vara, Aglaia Ntokou, Jui M. Dave, et al.
The Journal of Heart and Lung Transplantation (2022) Vol. 42, Iss. 5, pp. 544-552
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Cerebellin-2 promotes endothelial-mesenchymal transition in hypoxic pulmonary hypertension rats by activating NF-κB/HIF-1α/Twist1 pathway
E-Li Wang, Jie-Jie Zhang, Fangmei Luo, et al.
Life Sciences (2023) Vol. 328, pp. 121879-121879
Closed Access | Times Cited: 14
The role of lactate metabolism and lactylation in pulmonary arterial hypertension
Tao Peng, Jian-Liang Lu, Xiaojiao Zheng, et al.
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access
Functions and application of circRNAs in vascular aging and aging-related vascular diseases
Sen He, Bei Huang, Feng Xu, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Mfn2 regulates calcium homeostasis and suppresses PASMCs proliferation via interaction with IP3R3 to mitigate pulmonary arterial hypertension
R. Wang, Jie Wang, Jing Yu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Dysregulation of Mitochondrial in Pulmonary Hypertension-Related Right Ventricular Remodeling: Pathophysiological Features and Targeting Drugs
Yuehan Wang, Yingzhuo Wang, Weifang Zhang
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 3
Open Access
Identification of potential causal genes and drug targets in pulmonary hypertension based on transcriptomic analysis and Mendelian randomization
Chengliang Liu, Fanliang Meng
Postgraduate Medical Journal (2025)
Closed Access
Targeting necroptosis: a promising avenue for respiratory disease treatment
Xianya Cao, Junlan Tan, Runxiu Zheng, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
A novel dual fixation method for improving the reliable assessment of pulmonary vascular morphology in pulmonary hypertension rats
Yan Xu, Pu Liao, Xinyu Song, et al.
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access
Expression and regulation of HIF-1a in hypoxic pulmonary hypertension: Focus on pathological mechanism and Pharmacological Treatment
Jia-Jing Wan, Jian Yi, Fei-Ying Wang, et al.
International Journal of Medical Sciences (2023) Vol. 21, Iss. 1, pp. 45-60
Open Access | Times Cited: 8
Research progress of megakaryocytes and platelets in lung injury
Tianzhen Hua, Guangliang Zhang, Yi Yao, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 2
Osteopontin in Pulmonary Hypertension
Argen Mamazhakypov, Abdirashit Maripov, Akpay Sarybaev, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1385-1385
Open Access | Times Cited: 5
Environmental pollutants exposure-derived extracellular vesicles: crucial players in respiratory disorders
Haoran Shen, Rui Zheng, Mulong Du, et al.
Thorax (2024) Vol. 79, Iss. 7, pp. 680-691
Closed Access | Times Cited: 1
NOTCH3 and Pulmonary Arterial Hypertension
Nolan M. Winicki, Cristian Puerta, Casandra E. Besse, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6248-6248
Open Access | Times Cited: 1
A perfectly imperfect engine: Utilizing the digital twin paradigm in pulmonary hypertension
Melody Walker, Helen Moore, Ali Ataya, et al.
Pulmonary Circulation (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 1
The roles and regulatory mechanisms of cigarette smoke constituents in vascular remodeling
Si-Yuan Zhou, Jia-Min Du, Wenjing Li, et al.
International Immunopharmacology (2024) Vol. 140, pp. 112784-112784
Closed Access | Times Cited: 1
Inhibition of RUNX1 slows the progression of pulmonary hypertension by targeting CBX5
Ximiao Ma, Yiqiu Cao, Dongpeng Yang, et al.
Biomolecules and Biomedicine (2024)
Open Access | Times Cited: 1
A Non‐Metallic Nanozyme Ameliorates Pulmonary Hypertension Through Inhibiting ROS/TGF‐β1 Signaling
Ruxia Liu, Ting Zhou, Xinsheng Li, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 30
Closed Access | Times Cited: 1
Methyltransferase-Like 3–Driven N6-Methyladenosine Modification of RBPJ Promotes Vascular Remodeling in Pulmonary Hypertension
Qiang Du, Chun Zhang, Tianyu Qu, et al.
American Journal Of Pathology (2024) Vol. 194, Iss. 12, pp. 2252-2271
Closed Access | Times Cited: 1
Panorama of artery endothelial cell dysfunction in pulmonary arterial hypertension
Yuhui Shen, Dong Ding, Tian‐Yu Lian, et al.
Journal of Molecular and Cellular Cardiology (2024) Vol. 197, pp. 61-77
Closed Access | Times Cited: 1
Expression Profiles of circRNAs and Identification of hsa_circ_0007608 and hsa_circ_0064656 as Potential Biomarkers for COPD-PH Patients
Jinyan Yu, Shulun Huang, Weiyu Shen, et al.
International Journal of COPD (2023) Vol. Volume 18, pp. 2457-2471
Open Access | Times Cited: 2
Post-treatment with Resolvin D1 attenuates pulmonary hypertension by inhibiting endothelial-to-mesenchymal transition
Xinyu Li, Hui Li, Bo Feng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117023-117023
Open Access
CircLMBR1 inhibits phenotypic transformation of hypoxia-induced pulmonary artery smooth muscle via the splicing factor PUF60
Hongdan Wang, Yupei Gao, June Bai, et al.
European Journal of Pharmacology (2024) Vol. 980, pp. 176855-176855
Closed Access
Empagliflozin inhibits PASMCs Phenotypic transition via downexpressing SYK and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension
Yuchen Duan, Hong Wang, Guanghui Li, et al.
Research Square (Research Square) (2024)
Open Access
Mechanisms Controlling the Behavior of Vascular Smooth Muscle Cells in Hypoxic Pulmonary Hypertension
Lucie Bačáková, Antonín Sedlář, Jana Musı́lková, et al.
Physiological Research (2024), pp. S569-S596
Open Access
RO4929097 inhibits NICD3 to alleviate pulmonary hypertension via blocking Notch3/HIF-2α/FoxM1 signaling pathway
Hao Zhu, Cheng Li, Fang Hu, et al.
In Vitro Cellular & Developmental Biology - Animal (2024)
Closed Access
Page 1 - Next Page

Scroll to top